X0508 4 2024-07-22 0000946486 WINDTREE THERAPEUTICS INC /DE/ WINT 0001624401 Simonson Steven 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 1 SVP, Chief Medical Officer 0 Series C Preferred Stock 2024-07-22 4 A 0 13 A Common Stock 3471 13 D Warrants (Right to Buy) 4.11 2024-07-22 4 A 0 2674 A Common Stock 2674 2674 D On July 22, 2024, the Reporting Person acquired 13 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value ("Series C Preferred Stock"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the "Purchase Agreement"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date. Pursuant to the Purchase Agreement, the Reporting Person acquired 2,674 warrants to purchase 2,674 shares of the Issuer's common stock, $0.001 par value per share ("Warrants"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the "Initial Exercisability Date"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date. /s/ Jamie McAndrew, as Attorney-in-Fact 2024-07-24